세계의 초음파 전도성 젤 시장 전망(-2030년) : 제품별, 최종 사용자별, 지역별 시장 분석

According to Stratistics MRC, the Global Ultrasound Conductivity Gel Market is growing at a CAGR of 6.7% during the forecast period. Ultrasound conductivity gel is a water-based substance designed for medical imaging procedures employing ultrasound technology. It serves as a medium to transmit sound waves from the ultrasound probe into the body, ensuring clear visualization of internal structures. Formulated to possess high conductivity, it facilitates efficient transmission of ultrasound waves, enhancing imaging quality and accuracy. This gel is hypoallergenic, non-greasy, and easily washable, making it suitable for patient use

Market Dynamics:

Driver:

Rising demand for diagnostic imaging

Ultrasound imaging stands out as a preferred modality due to its versatility, safety, cost-effectiveness, and real-time imaging capabilities. It ensures optimal acoustic transmission, reduces air pockets that can distort images, and enhances the clarity of ultrasound scans. Therefore, the expanding utilization of ultrasound imaging translates directly into higher demand for ultrasound conductivity gel across hospitals, clinics, diagnostic centers, and other healthcare facilities, thereby propelling this market further.

Restraint:

High production costs

The formulation and composition of the gel are two of the factors contributing to high production costs. The gel is typically packaged in sterile containers or tubes with product information, instructions for use, and safety warnings, leading to increased production costs. Furthermore, factors such as research and development investments, ongoing product testing, and clinical evaluations can increase the overall cost of introducing ultrasound conductivity gel, significantly impeding market expansion.

Opportunity:

Growing awareness and accessibility of healthcare

As healthcare awareness increases, individuals are more likely to seek preventive care and early diagnosis of medical conditions. This increased utilization of ultrasound imaging translates directly into a higher demand for ultrasound gel, as it is essential for achieving clear and accurate ultrasound images. Moreover, ultrasound imaging, being a safe, non-invasive, and widely accessible diagnostic tool, becomes an integral part of routine healthcare screenings and diagnostic procedures, which gradually boosts market growth.

Threat:

Environmental affects

The energy consumption and water usage during production can contribute to greenhouse gas emissions and strain local water resources, potentially leading to pollution and contamination. The disposal of used ultrasound conductivity gel also presents environmental challenges. Additionally, improper disposal, such as disposal in regular waste streams, can result in the gel entering waterways or soil, causing pollution and potentially harming aquatic life and ecosystems, thereby hindering the market size.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the ultrasound conductivity gel market. The pandemic led to disruptions in non-essential healthcare services, including elective diagnostic procedures such as ultrasound examinations. Further, restrictions on international trade, border closures, and lockdown measures disrupted the global supply chain for medical supplies, leading to shortages and delays in the availability of ultrasound gel products, hampering the market's supply side.

The sterile gels segment is expected to be the largest during the forecast period

The sterile gels segment is estimated to hold the largest share, due to a specific category of ultrasound gels that have undergone a sterilization process to ensure they are free from microorganisms and suitable for use in sterile medical procedures. This involves employing methods such as gamma irradiation or ethylene oxide (EtO) sterilization that could compromise patient safety during ultrasound-guided procedures. Furthermore, these gels are typically utilized in critical medical environments which gradually drive this segment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have highest CAGR during the forecast period due to their demand for ultrasound conductivity gel in significant quantities due to the high volume of ultrasound procedures performed daily. Factors such as the growing prevalence of chronic diseases and technological advancements in ultrasound imaging contribute to the sustained demand for ultrasound gel in hospitals. Additionally, hospitals may prefer purchasing from reputable suppliers that provide consistent product quality and reliable customer support to ensure uninterrupted workflow and patient care, which is driving this segment's growth.

Region with largest share:

Europe commanded the largest market share during the extrapolated period owing to advanced medical infrastructure and robust regulatory frameworks. This region is home to some of the major key players, such as Parker Laboratories, Inc., Medline Industries, Inc., and Eco-Med Diagnostic Imaging, Inc. Moreover, technological advancements in ultrasound imaging equipment enhance the accuracy and efficiency of diagnostic procedures, further stimulating the demand for high-quality ultrasound gel in this region.

Region with highest CAGR:

Asia Pacific is expected to witness highest CAGR over the projection period, owing to a significant demographic dividend characterized by a large population base and a rising middle class. Countries like China, India, Japan, South Korea, and Southeast Asian nations are raising the demand for diagnostic imaging procedures, including ultrasound examinations. Furthermore, government schemes and programs are contributing to the growth of the ultrasound conductivity gel market in the Asia Pacific region.

Key players in the market

Some of the key players in the Ultrasound Conductivity Gel Market include Parker Laboratories, Inc., Cardinal Health, Inc., Modul Diagram S.r.l, Pharmaceutical Innovation Inc., Medline Industries Inc., ECO-MED Diagnostic Imaging, AiM Medical Technologies, Roscoe Medical, DJO Global, Inc., National Therapy Products Inc., Ceracarta Spa, Phyto Performance Italia S.R.L and Trivitron Healthcare Pvt.

Key Developments:

In November 2022, Parker Laboratories Inc. showcased its ultrasound equipment at MEDICA 2022. The showcase included the Aquasonic 100 Ultrasound Transmission Gel.

In May 2022, Trivitron Healthcare announced that it has developed the Real-Time PCR-based kit for the detection of monkeypox (orthopoxvirus) virus, which has become a disease of global public health importance as it not only affects countries in West and Central Africa, but is also spreading at a fast pace globally.

Products Covered:

• Non Sterile Gels
• Sterile Gels
• Other Products

End Users Covered:

• Ambulatory Surgical Centres
• Hospitals
• Clinics
• Diagnostic Centres
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Ultrasound Conductivity Gel Market, By Product

• 5.1 Introduction
• 5.2 Non Sterile Gels
• 5.3 Sterile Gels
• 5.4 Other Products

6 Global Ultrasound Conductivity Gel Market, By End User

• 6.1 Introduction
• 6.2 Ambulatory Surgical Centres
• 6.3 Hospitals
• 6.4 Clinics
• 6.5 Diagnostic Centres
• 6.6 Other End Users

7 Global Ultrasound Conductivity Gel Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Parker Laboratories, Inc.
• 9.2 Cardinal Health, Inc.
• 9.3 Modul Diagram S.r.l
• 9.4 Pharmaceutical Innovation Inc.
• 9.5 Medline Industries Inc.
• 9.6 ECO-MED Diagnostic Imaging
• 9.7 AiM Medical Technologies
• 9.8 Roscoe Medical
• 9.9 DJO Global, Inc.
• 9.10 National Therapy Products Inc.
• 9.11 Ceracarta Spa
• 9.12 Phyto Performance Italia S.R.L
• 9.13 Trivitron Healthcare Pvt